(Q42637517)

4 November 2017

title

Cost-benefit analysis of sumatriptan tablets versus usual therapy for treatment of migraine (English)

1 reference

4 November 2017

1 reference

cost–benefit analysis

1 reference

Biddle AK

1

1 reference

4 November 2017

Shih YC

series ordinal

2

1 reference

4 November 2017

Kwong WJ

series ordinal

3

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 November 2000

1 reference

4 November 2017

1 reference

4 November 2017

volume

20

1 reference

4 November 2017

issue

11

1 reference

4 November 2017

page(s)

1356-1364

1 reference

Impact of migraine in the United States: data from the National Health Interview Survey

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.17.1356.34890

Healthcare resource and lost labour costs of migraine headache in the US.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.17.1356.34890

Measuring the functional status and well-being of patients with migraine headache.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.17.1356.34890

Rizatriptan (MAXALT) for the acute treatment of migraine and migraine recurrence. A placebo-controlled, outpatient study. Rizatriptan 022 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.17.1356.34890

Impact of sumatriptan on workplace productivity, nonwork activities, and health-related quality of life among hospital employees with migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.17.1356.34890

Comparing dihydroergotamine mesylate and sumatriptan in the management of acute migraine. A retrospective cost-efficacy analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.17.1356.34890

Sumatriptan injection reduces productivity loss during a migraine attack: results of a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.17.1356.34890

Quality-of-life assessment in patients with headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.17.1356.34890

Sumatriptan treatment for migraine in a health maintenance organization: economic, humanistic, and clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.17.1356.34890

The willingness to pay for in vitro fertilization: a pilot study using contingent valuation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.17.1356.34890

A multinational investigation of the impact of subcutaneous sumatriptan. I: Design, methods and clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.20.17.1356.34890

10.1592/PHCO.20.17.1356.34890

21 January 2018

Identifiers

DOI

1 reference

4 November 2017

1 reference